• activation;
  • progelatinase B;
  • collagenase-3;
  • matrix metalloproteinases


  1. Top of page
  2. Abstract
  3. References

Human progelatinase B was activated by collagenase-3 in a time-dependent fashion. Activation proceeded through an intermediate form of Mr 86000 to the final active form of Mr 82000. N-terminal amino acid sequence determination demonstrated that the Glu40–Met41 peptide bond was initially hydrolysed followed by cleavage of the Arg87–Phe88 peptide bond releasing the rest of the propeptide domain which was accompanied by the achievement of maximal enzymatic activity as revealed using a quenched fluorescent substrate. Kinetic analysis of activation revealed that the rates were dependent on the concentration of the proenzyme as well as active collagenase-3. Active gelatinase B did not contribute to the activation rate of the proenzyme initiated by collagenase-3 and our results indicate that progelatinase B activation proceeds via bimolecular cleavage with collagenase-3 involving sequential cleavage of the propeptide in two steps. The activation rates were not dependent on C-terminal domain interactions between progelatinase B and collagenase-3, as assessed using wild-type and C-terminal deletion mutants of both enzymes.

Since elevated levels of both gelatinase B and collagenase-3 have been observed in arthritis and breast cancer pathology these enzymes may well form a proteolytic cascade in these diseases which allows rapid turnover of the extracellular matrix.


matrix metalloproteinase


tissue inhibitor of metalloproteinase


membrane-type matrix metalloproteinase


gelatinase B




aminophenyl mercuric acetate


(7-meth-oxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2, 3-diaminopropyl]Ala-Arg-NH2




urokinase-like plasminogen activator


urokinase-plasminogen-activator receptor


  1. Top of page
  2. Abstract
  3. References
  • 1
    Freije, J. M. P., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J. & López-Otin, C. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J. Biol. Chem. 269, 1676616773.
  • 2
    Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F. & Hambor, J. E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage, J. Clin. Invest. 97, 761768.
  • 3
    Heppner, K. J., Matrisian, L. M., Jensen, R. A. & Rodgers, W. H. (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response, Am. J. Pathol. 149, 273282.
  • 4
    Mohtai, M., Smith, R. L., Schurman, D. J., Tsuji, Y., Torti, F. M., Hutchinson, N. I., Stetler-Stevenson, W. G. & Goldberg, G. I. (1993) Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1, J. Clin. Invest. 92, 179185.
  • 5
    Himelstein, B. P. & Muschel, R. J. (1996) Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts, Clin. Exp. Metastasis 14, 197208.
  • 6
    Kurogi, T., Nabeshima, K., Kataoka, H., Okada, Y. & Koono, M. (1996) Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteo-sarcoma cells and human fibroblasts: gelatinase-B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor, Int. J. Cancer 66, 8290.
  • 7
    Knäuper, V., López-Otin, C., Smith, B., Knight, G. & Murphy, G. (1996) Biochemical characterization of human collagenase-3, J. Biol. Chem. 271, 15441550.
  • 8
    Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M. & Murphy, G. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation – Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme, J. Biol. Chem. 271, 1712417131.
  • 9
    Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M. & Welgus, H. G. (1995) Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP), J. Biol. Chem. 270, 63516356.
  • 10
    Fridman, R., Toth, M., Peña, D. & Mobashery, S. (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2), Cancer Res. 55, 25482555.
  • 11
    Ogata, Y., Itoh, Y. & Nagase, H. (1995) Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases, J. Biol. Chem. 270, 1850618511.
  • 12
    Sang, Q. X., Birkedal-Hansen, H. & Van Wart, H. E. (1995) Proteolytic and non-proteolytic activation of human neutrophil progelatinase B, Biochim. Biophys. Acta 1251, 99108.
  • 13
    Pei, D. Q. & Weiss, S. J. (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity, J. Biol. Chem. 277, 91359140.
  • 14
    Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells, Nature 370, 6165.
  • 15
    Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. & Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease, J. Biol. Chem. 270, 53315338.
  • 16
    Atkinson, S. J., Crabbe, T., Cowell, S., Ward, R. V., Butler, M. J., Sato, H., Seiki, M., Reynolds, J. J. & Murphy, G. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes, J. Biol. Chem. 270, 3047930485.
  • 17
    O'Connell, I. P., Willenbrock, F., Docherty, A. J. P., Eaton, D. & Murphy, G. (1994) Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B, J. Biol. Chem. 269, 1496714973.
  • 18
    Knäuper, V., Cowell, S., Smith, B., López-Otin, C., O'Shea, M., Morris, H., Zardi, L. & Murphy, G. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity and tissue inhibitor of metalloproteinase (TIMP) interaction, J. Biol. Chem. 271, 76087616.
  • 19
    Moore, W. H., Spilburg, C. A., Hirsch, S. K., Evans, C. L., Wester, W. N. & Martin, R. A. (1986) Purification of human collagenases with a hydroxamic acid affinity column, Biochemistry 25, 51895195.
  • 20
    Murphy, G. & Willenbrock, F. (1995) Tissue inhibitor of matrix metalloendopeptidases. Methods Enzymol. 248, 496510.
  • 21
    Knight, C. G., Willenbrock, F. & Murphy, G. (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases, FEBS Lett. 296, 263266.
  • 22
    Ogata, Y., Itoh, Y. & Nagase, H. (1995) Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases, J. Biol. Chem. 270, 1850618511.
  • 23
    Ward, R. V., Atkinson, S. J., Reynolds, J. J. & Murphy, G. (1994) Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts, Biochem. J. 304, 263269.
  • 24
    Becker, J. W., Marcy, A. I., Rokosz, L. L., Axel, M. G., Burbaum, J. J., Fitzgerald, P. M. D., Cameron, P. M., Esser, C. K., Hagmann, W. K., Hermes, J. D. & Springer, J. P. (1995) Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme, Protein Sci. 4, 19661976.
  • 25
    Ståhle-Bäckdahl, M., Sandstedt, B., Bruce, K., Lindahl, A., Jiménez, M. G., Vega, J. A. & López-Otin, C. (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in pastnatal bone remodelling and in rheumatoid arthritis, Lab. Invest. 76, 717728.
  • 26
    Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I. & Tryggvason, K. (1994) High expression of 92 kDa type IV collagenase (gela-tinase B) in the osteoclast lineage during mouse development, J. Cell Biol. 124, 10911102.
  • 27
    Sakiyama, H., Inaba, N., Toyoguchi, T., Okada, Y., Matsumoto, M., Moriya, H. & Ohtsu, H. (1994) Immunolocalisation of complement C1s and matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur, Cell Tissue Res. 277, 239245.
  • 28
    Murphy, G., Ward, R., Gavrilovic, J. & Atkinson, S. (1992) Physiological mechanisms for metalloproteinase activation, Matrix Suppl. 1, 224230.
  • 29
    Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K. & Hayakawa, T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties, J. Biol Chem. 267, 2171221719.
  • 30
    Cao, J., Rehemtulla, A., Bahou, W. & Zucker, S. (1996) Membrane type matrix metalloproteinase 1 activates progelatinase A without furin cleavage of the N-terminal domain, J. Biol. Chem. 271, 3017430180.